Tech Company Inital Public Offerings

Xilio Therapeutics IPO

Xilio Therapeutics, based in Waltham, debuted as a public company on 10/22/2021.

Transaction Overview

Company Name
Announced On
Transaction Type
Proceeds Purpose
We intend to use the net proceeds from this offering to advance the development of XTX202 through Phase 1 dose escalation and Phase 2 efficacy cohorts of our planned Phase 1/2 trial in patients with solid tumors; to advance the development of XTX301 through investigational new drug application, or IND, enabling studies, submission of an IND to the U.S. Food and Drug Administration and into initial Phase 1 development; to advance the development of XTX101 through Phase 1 dose escalation and to initiate activities for Phase 2 development; and to advance additional tumor-selective cytokine programs and for working capital and other general corporate purposes.

Company Information

Company Status
Mailing Address
828 Winter St.
Waltham, MA 02451
Email Address
Not Recorded
Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company's proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body -- a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang.
Xilio Therapeutics LinkedIn Company Profile
Social Media
Xilio Therapeutics Company Twitter Account
Company News
Xilio Therapeutics News
Xilio Therapeutics on Facebook
Xilio Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Rene Russo
  Rene Russo LinkedIn Profile  Rene Russo Twitter Account  Rene Russo News  Rene Russo on Facebook
Chief Medical Officer
Marty Huber
  Marty Huber LinkedIn Profile  Marty Huber Twitter Account  Marty Huber News  Marty Huber on Facebook
Chief Operating Officer
Joseph Farmer
  Joseph Farmer LinkedIn Profile  Joseph Farmer Twitter Account  Joseph Farmer News  Joseph Farmer on Facebook
Timothy Clackson
  Timothy Clackson LinkedIn Profile  Timothy Clackson Twitter Account  Timothy Clackson News  Timothy Clackson on Facebook
VP - R & D
Ronan O'Hagan
  Ronan O'Hagan LinkedIn Profile  Ronan O'Hagan Twitter Account  Ronan O'Hagan News  Ronan O'Hagan on Facebook



Browse more venture capital transactions:

Prev: 10/22/2021: CollateralEdge venture capital transaction
Next: 10/22/2021: Bites venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary